Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease

Inflammatory bowel disease (IBD) such as Crohn’s disease and ulcerative colitis is a chronic autoimmune disease affecting nearly five million people worldwide. Among all drug delivery system, oral administration is the most preferable route for colon-specific targeting and the treatment of IBD. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Hongzhi, Fang, Dong, Chen, Jing, Sun, Yuan, Kang, Chen, Di, Liuqing, Li, Junsong, Chen, Zhipeng, Chen, Jun, Gao, Yahan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240970/
https://www.ncbi.nlm.nih.gov/pubmed/28156160
http://dx.doi.org/10.1080/10717544.2016.1245367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240970/
https://www.ncbi.nlm.nih.gov/pubmed/28156160
http://dx.doi.org/10.1080/10717544.2016.1245367

Ejemplares similares